To the full analysis
DiaSorin stock: growth
DIA.MIDiaSorin reported $1.32B in revenue for fiscal 2025, up 0.8% on the prior year, up 6.3% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
10.5%
per year from 2006 to 2025, per share 9.8%
Earnings (Annual rate)
10.8%
per year from 2006 to 2025, per share 10%
Free cash flow (Annual rate)
14.3%
per year from 2006 to 2025, per share 13.6%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 6.3% | 9.1% | 10.5% |
| Revenue per share | 5.8% | 8.9% | 9.8% |
| Earnings | −8.9% | 4.5% | 10.8% |
| Earnings per share | −9.4% | 4.2% | 10.0% |
| Free cash flow | −2.2% | 6.8% | 14.3% |
| Free cash flow per share | −2.7% | 6.6% | 13.6% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $199.19M | $24.7M | $17.96M |
| 2007 | $224.2M | $27.95M | $15.29M |
| 2008 | $271.05M | $41.51M | $31.76M |
| 2009 | $337.01M | $77.62M | $40.65M |
| 2010 | $448.28M | $100.19M | $74.7M |
| 2011 | $487.57M | $110.37M | $88.25M |
| 2012 | $480.65M | $96.84M | $86.13M |
| 2013 | $481.86M | $92M | $83.79M |
| 2014 | $491.74M | $93.16M | $98.77M |
| 2015 | $553.14M | $111.28M | $117.9M |
| 2016 | $630.85M | $124.53M | $142.03M |
| 2017 | $706.4M | $155M | $138.47M |
| 2018 | $741.54M | $175.22M | $174.07M |
| 2019 | $782.67M | $194.73M | $196M |
| 2020 | $976.57M | $274.67M | $254.57M |
| 2021 | $1.37B | $344.58M | $313.91M |
| 2022 | $1.51B | $266.95M | $305.45M |
| 2023 | $1.27B | $177.13M | $294.97M |
| 2024 | $1.31B | $208.44M | $264.91M |
| 2025 | $1.32B | $172.45M | $227.25M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = €0.9024)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 18 Oct 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.